G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69 | -21.6% | 25,820 | +58.5% | 0.01% | -33.3% |
| Q4 2022 | $88 | -100.0% | 16,291 | +9.3% | 0.01% | -50.0% |
| Q3 2022 | $186,000 | +1.1% | 14,901 | -38.4% | 0.02% | -18.2% |
| Q1 2022 | $184,000 | -23.3% | 24,187 | +81.6% | 0.02% | -43.6% |
| Q4 2020 | $240,000 | +3.4% | 13,319 | -33.7% | 0.04% | +5.4% |
| Q3 2020 | $232,000 | +5.9% | 20,085 | +122.9% | 0.04% | +12.1% |
| Q2 2020 | $219,000 | -2.2% | 9,010 | -33.2% | 0.03% | -10.8% |
| Q1 2019 | $224,000 | -18.2% | 13,488 | +157.9% | 0.04% | -2.6% |
| Q3 2018 | $274,000 | – | 5,230 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
| CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
| Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
| Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
| Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
| Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
| Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |